Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kasper Lamberth

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Plos One|May 15, 2018
The effect of acylation with fatty acids and other modifications on HLA class II:peptide binding and T cell stimulation for three model peptidesHeidi S Schultz, Søren Østergaard, John Sidney, et al.
Journal of Biomolecular Screening|February 7, 2009
Peptide binding to HLA class I molecules: homogenous, high-throughput screening, and affinity assaysMikkel Harndahl, Sune Justesen, Kasper Lamberth, et al.
European Journal of Gastroenterology & Hepatology|March 1, 2003
Ca2+ response in neutrophils after exposure to bacterial N-formyl-methionyl-leucyl-phenylalanine: delayed response in ulcerative colitisBen Vainer, Kasper Lamberth, Jens Brimnes, et al.
Nucleic Acids Research|May 9, 2008
NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11Claus Lundegaard, Kasper Lamberth, Mikkel Harndahl, et al.
Immunome Research|May 7, 2009
Functional recombinant MHC class II molecules and high-throughput peptide-binding assaysSune Justesen, Mikkel Harndahl, Kasper Lamberth, et al.
BMC Bioinformatics|November 2, 2007
Large-scale validation of methods for cytotoxic T-lymphocyte epitope predictionMette V Larsen, Claus Lundegaard, Kasper Lamberth, et al.
Protein Science : a Publication of the Protein Society|April 24, 2009
Recombinant chymosin used for exact and complete removal of a prochymosin derived fusion tag releasing intact native target proteinSune F L Justesen, Kasper Lamberth, Lise-Lotte B Nielsen, et al.
European Journal of Immunology|July 6, 2005
An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictionsMette Voldby Larsen, Claus Lundegaard, Kasper Lamberth, et al.
European Journal of Immunology|November 25, 2003
Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variantsReinhold Schirmbeck, Nektarios Dikopoulos, Marcin Kwissa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2009
Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potentialPetra Riedl, Andreas Wieland, Kasper Lamberth, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Plos One|May 15, 2018
The effect of acylation with fatty acids and other modifications on HLA class II:peptide binding and T cell stimulation for three model peptidesHeidi S Schultz, Søren Østergaard, John Sidney, et al.
Journal of Biomolecular Screening|February 7, 2009
Peptide binding to HLA class I molecules: homogenous, high-throughput screening, and affinity assaysMikkel Harndahl, Sune Justesen, Kasper Lamberth, et al.
European Journal of Gastroenterology & Hepatology|March 1, 2003
Ca2+ response in neutrophils after exposure to bacterial N-formyl-methionyl-leucyl-phenylalanine: delayed response in ulcerative colitisBen Vainer, Kasper Lamberth, Jens Brimnes, et al.
Nucleic Acids Research|May 9, 2008
NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11Claus Lundegaard, Kasper Lamberth, Mikkel Harndahl, et al.
Immunome Research|May 7, 2009
Functional recombinant MHC class II molecules and high-throughput peptide-binding assaysSune Justesen, Mikkel Harndahl, Kasper Lamberth, et al.
BMC Bioinformatics|November 2, 2007
Large-scale validation of methods for cytotoxic T-lymphocyte epitope predictionMette V Larsen, Claus Lundegaard, Kasper Lamberth, et al.
Protein Science : a Publication of the Protein Society|April 24, 2009
Recombinant chymosin used for exact and complete removal of a prochymosin derived fusion tag releasing intact native target proteinSune F L Justesen, Kasper Lamberth, Lise-Lotte B Nielsen, et al.
European Journal of Immunology|July 6, 2005
An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictionsMette Voldby Larsen, Claus Lundegaard, Kasper Lamberth, et al.
European Journal of Immunology|November 25, 2003
Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variantsReinhold Schirmbeck, Nektarios Dikopoulos, Marcin Kwissa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2009
Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potentialPetra Riedl, Andreas Wieland, Kasper Lamberth, et al.
Pageof 4